Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-10.2%/yr
vs +31.4%/yr prior
5Y CAGR
-3.6%/yr
Recent deceleration
Acceleration
-41.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $105.21M | -8.9% |
| 2024 | $115.44M | -12.5% |
| 2023 | $131.88M | -9.3% |
| 2022 | $145.40M | +1.1% |
| 2021 | $143.85M | +13.8% |
| 2020 | $126.42M | +19.9% |
| 2019 | $105.42M | +115.8% |
| 2018 | $48.85M | +96.4% |
| 2017 | $24.87M | +3.9% |
| 2016 | $23.95M | - |